Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91(14):1194–1210.
   PubMedGoogle Scholar
• Loeb LA, Ernster VL, Warner KE, et al. Smoking and lung cancer: an overview. Cancer Res. 1984;44(12 Pt 1):5940–5958.
   PubMed Web of Science ®Google Scholar
• Sands J, Tammemägi MC, Couraud S, et al. Lung Screening Benefits and Challenges: a Review of The Data and Outline for Implementation. J Thorac Oncol. 2021;16(1):37–53.
   PubMed Web of Science ®Google Scholar
• Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–594.
   PubMed Web of Science ®Google Scholar
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med. 2011:365(5):395–409.
   PubMed Web of Science ®Google Scholar
• Stein JE, Lipson EJ, Cottrell TR, et al. Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade. Clin Cancer Res. 2020;26(3):545–551.
   PubMed Web of Science ®Google Scholar
• Lord CJ, The AA. DNA damage response and cancer therapy. Nature. 2012;481(7381):287–294.
   PubMed Web of Science ®Google Scholar
• Caldecott KW. XRCC1 and DNA strand break repair. DNA Repair (Amst). 2003;2(9):955–969.
   PubMed Web of Science ®Google Scholar
• Caldecott KW. Single-strand break repair and genetic disease. Nat Rev Genet. 2008;9(8):619–631.
   PubMed Web of Science ®Google Scholar
• Mari P-O, Florea BI, Persengiev SP, et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl Acad Sci U S A. 2006;103(49):18597–18602.
   PubMed Web of Science ®Google Scholar
• Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211.
   PubMed Web of Science ®Google Scholar
• Thacker J, Zdzienicka MZ. The XRCC genes: expanding roles in DNA double-strand break repair. DNA Repair (Amst). 2004;3(8–9):1081–1090.
   PubMed Web of Science ®Google Scholar
• Liu N, Lamerdin JE, Tebbs RS, et al. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell. 1998;1(6):783–793.
   PubMed Web of Science ®Google Scholar
• Thacker J, Zdzienicka MZ. The mammalian XRCC genes: their roles in DNA repair and genetic stability. DNA Repair (Amst). 2003;2(6):655–672.
   PubMed Web of Science ®Google Scholar
• Scully R, Panday A, Elango R, et al. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Biol. 2019;20(11):698–714.
   PubMed Web of Science ®Google Scholar
• O’Connor MJ. Targeting the DNA Damage Response in Cancer. Mol Cell. 2015;60(4):547–560.
   PubMed Web of Science ®Google Scholar
• Sealfon SC, Chu TT. RNA and DNA microarrays. Methods Mol Biol. 2011;671:3–34.
   PubMedGoogle Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404.
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514.
   PubMed Web of Science ®Google Scholar
• Franz M, Rodriguez H, Lopes C, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):W60–W64.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–D361.
   PubMed Web of Science ®Google Scholar
• Hou J, Aerts J, den Hamer B, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 2010;5(4):e10312.
   PubMed Web of Science ®Google Scholar
• Selamat SA, Chung BS, Girard L, et al. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res. 2012;22(7):1197–1211.
   PubMed Web of Science ®Google Scholar
• Su LJ, Chang CW, Wu YC, et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics. 2007;8:140.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A. 2001;98(24):13790–13795.
   PubMed Web of Science ®Google Scholar
• Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 2001;98(24):13784–13789.
   PubMed Web of Science ®Google Scholar
• Talbot SG, Estilo C, Maghami E, et al. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res. 2005;65(8):3063–3071.
   PubMed Web of Science ®Google Scholar
• Yamagata N, Shyr Y, Yanagisawa K, et al. A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2003;9(13):4695–4704.
   PubMed Web of Science ®Google Scholar
• Stankovic B, Bjorhovde HAK, Skarshaug R, et al. Immune Cell Composition in Human Non-small Cell Lung Cancer. Front Immunol. 2018;9:3101.
   PubMed Web of Science ®Google Scholar
• Wakabayashi O, Yamazaki K, Oizumi S, et al. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci. 2003;94(11):1003–1009.
   PubMed Web of Science ®Google Scholar
• Hiraoka K, Miyamoto M, Cho Y, et al. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer. 2006;94(2):275–280.
   PubMed Web of Science ®Google Scholar
• Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015 Jan;43(Database issue):D1049-56. doi: 10.1093/nar/gku1179. Epub 2014 Nov 26.
   Google Scholar
• Kucab JE, Zou X, Morganella S, et al. A Compendium of Mutational Signatures of Environmental Agents. Cell. 2019;177(4):821–836. e816.
   PubMed Web of Science ®Google Scholar
• Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92(11):874–897.
   PubMedGoogle Scholar
• Thompson LH, Brookman KW, Jones NJ, et al. Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol. 1990;10(12):6160–6171.
   PubMed Web of Science ®Google Scholar
• Miao X, Zhang X, Zhang L, et al. Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer. Gastroenterology. 2006;131(2):420–427.
   PubMed Web of Science ®Google Scholar
• Duell EJ, Holly EA, Bracci PM, et al. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res. 2002;62(16):4630–4636.
   PubMed Web of Science ®Google Scholar
• Hao B, Miao X, Li Y, et al. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene. 2006;25(25):3613–3620.
   PubMed Web of Science ®Google Scholar
• Lin WY, Camp NJ, Cannon-Albright LA, et al. A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet. 2011;48(7):477–484.
   PubMed Web of Science ®Google Scholar
• Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 2006;27(3):560–567.
   PubMed Web of Science ®Google Scholar
• Jiao L, Hassan MM, Bondy ML, et al. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol. 2008;103(2):360–367.
   PubMed Web of Science ®Google Scholar
• Saeed S, Mahjabeen I, Sarwar R, et al. Haplotype analysis of XRCC2 gene polymorphisms and association with increased risk of head and neck cancer. Sci Rep. 2017;7:1.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Z, Xu Z, et al. Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy. Cell Death Dis. 2018;9(4):420.
   PubMedGoogle Scholar
• Griffin CS, Simpson PJ, Wilson CR, et al. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol. 2000;2(10):757–761.
   PubMed Web of Science ®Google Scholar
• Jacobsen NR, Raaschou-Nielsen O, Nexo B, et al. XRCC3 polymorphisms and risk of lung cancer. Cancer Lett. 2004;213(1):67–72.
   PubMed Web of Science ®Google Scholar
• Yang CR, Yeh S, Leskov K, et al. Isolation of Ku70-binding proteins (KUBs). Nucleic Acids Res. 1999;27(10):2165–2174.
   PubMed Web of Science ®Google Scholar
• Tseng RC, Hsieh FJ, Shih CM, et al. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study. Cancer. 2009;115(13):2939–2948.
   PubMed Web of Science ®Google Scholar
• He F, Chang SC, Wallar GM, et al. Association of XRCC3 and XRCC4 gene polymorphisms, family history of cancer and tobacco smoking with non-small-cell lung cancer in a Chinese population: a case-control study. J Hum Genet. 2013;58(10):679–685.
   PubMed Web of Science ®Google Scholar
• Ye J, Ren Z, Gu Q, et al. Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice. DNA Cell Biol. 2011;30(12):987–994.
   PubMed Web of Science ®Google Scholar
• Wang B, Xie M, Li R, et al. Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis. Cell Death Differ. 2014;21(7):1160–1169.
   PubMed Web of Science ®Google Scholar
• Li M, Li JJ, Gu QH, et al. EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation. Oncol Rep. 2016;35(4):2339–2347.
   PubMed Web of Science ®Google Scholar
• Ma Q, Li P, Xu M, et al. Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance. J Exp Clin Cancer Res. 2012;31(1):99.
   PubMedGoogle Scholar
• Ye J, Ren Z, Gu Q, et al. Ku80 Is Differentially Expressed in Human Lung Carcinomas and Upregulated in Response to Irradiation in Mice. DNA Cell Biol. 2011;30(12):987–994.
   PubMed Web of Science ®Google Scholar
• Ma Q, Li P, Xu M, et al. Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance. J Exp Clin Cancer Res. 2012;31:99.
   PubMed Web of Science ®Google Scholar
• Seijo LM, Peled N, Ajona D, et al. Biomarkers in Lung Cancer Screening: achievements, Promises, and Challenges. J Thorac Oncol. 2019;14(3):343–357.
   PubMed Web of Science ®Google Scholar
• Nassar FJ, Nasr R, Talhouk R. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction. Pharmacol Ther. 2017;172:34–49.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL. van ‘t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5(8):591–602.
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Yashiro M. Biomarkers of gastric cancer: current topics and future perspective. World J Gastroenterol. 2018;24(26):2818–2832.
   PubMed Web of Science ®Google Scholar